Tanabe Pharma Corporation
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (125)
Effects of Iron Supplements on the Pharmacokinetics of MT-6548
Started: 8/27/2018
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Started: 2/14/2018
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Started: 3/5/2018
Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
Started: 10/30/2017
Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
Started: 1/3/2018
Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus
Started: 5/1/2011
The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Started: 4/1/2013
Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
Started: 7/1/2011
A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis
Started: 3/1/2013
A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
Started: 7/1/2012
Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Started: 12/1/2008
Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
Started: 1/1/2012
A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Started: 6/1/2013
Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
Started: 2/1/2012
Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
Started: 2/15/2018
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Started: 8/1/2011
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
Started: 1/1/2015
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
Started: 3/1/2009
Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
Started: 8/1/2014
Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)
Started: 12/1/2008
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
Started: 1/1/2015
Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
Started: 5/1/2012
Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease
Started: 3/1/2012
Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
Started: 12/1/2011
Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)
Started: 12/1/2012
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients
Started: 5/1/2012
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
Started: 11/1/2008
Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C
Started: 12/1/2012
Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
Started: 6/23/2017
Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus
Started: 9/1/2016
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients
Started: 11/1/2011
Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus
Started: 9/1/2016
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy
Started: 12/1/2008
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Started: 4/1/2014
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
Started: 11/1/2008
Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes
Started: 9/1/2009
Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes
Started: 12/1/2009
Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
Started: 8/1/2009
Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus
Started: 2/1/2010
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
Started: 2/1/2011
Monotherapy Study of MP-513 in Patients With Type 2 Diabetes
Started: 9/1/2009
Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS
Started: 10/26/2022
A Study of MT-0551 in Patients With Systemic Sclerosis
Started: 7/20/2022
Safety Study of MT-4666 in Subjects With Alzheimer's Disease
Started: 12/1/2014
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
Started: 11/17/2017
An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
Started: 11/1/2009
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
Started: 2/1/2009
Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain
Started: 9/8/2017
Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes
Started: 8/1/2009
Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
Started: 6/21/2017
Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C
Started: 1/1/2008
Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II
Started: 4/1/2009
Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis
Started: 6/1/2010
A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia
Started: 5/1/2012
Safety and Efficacy of MP-214 in Patients With Schizophrenia
Started: 5/1/2012
Long-Term Study of MP-214 in Patients With Schizophrenia
Started: 9/1/2012
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
Started: 5/1/2012
A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia
Started: 5/1/2012
Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia
Started: 4/1/2008
Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes
Started: 1/1/2008
Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy
Started: 11/16/2021
Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy
Started: 7/25/2017
Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
Started: 9/1/2016
An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy
Started: 2/1/2016
Extension Study of MT-1303 in Subjects With Crohn's Disease
Started: 8/1/2015
Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
Started: 7/1/2015
Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
Started: 3/1/2015
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
Started: 12/1/2012
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
Started: 11/1/2012
Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Started: 9/1/2013
The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.
Started: 6/24/2025
A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects
Started: 9/18/2018
A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL
Started: 1/30/2023
An Exploratory Study of MT-2990 in Patients With AAV
Started: 6/24/2024
Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment
Started: 10/27/2016
Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients
Started: 6/1/2008
PK Study in Subjects With Severe Hepatic Impairment
Started: 11/6/2018
Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment
Started: 11/16/2016
A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
Started: 1/1/2012
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)
Started: 6/10/2019
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis
Started: 4/17/2019
Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
Started: 3/22/2019
Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy
Started: 1/24/2020
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)
Started: 10/17/2018
Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube
Started: 2/26/2021
Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
Started: 10/1/2013
A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C
Started: 4/1/2008
A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects
Started: 8/1/2015
A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
Started: 2/1/2016
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms
Started: 6/1/2016
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects
Started: 4/1/2015
A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
Started: 7/17/2018
Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers
Started: 8/9/2024
A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)
Started: 5/2/2022
A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males
Started: 8/3/2022
Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants
Started: 7/3/2018
A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers
Started: 5/17/2017
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects
Started: 7/1/2016
Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients
Started: 2/1/2015
A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers
Started: 11/1/2016
Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
Started: 7/1/2014
Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy
Started: 7/1/2013
Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease
Started: 5/1/2014
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease
Started: 6/1/2012
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects
Started: 3/1/2008
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects
Started: 8/1/2009
Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
Started: 8/1/2014
Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus
Started: 8/1/2014
Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
Started: 12/1/2014
Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes
Started: 1/1/2014